A 5-year evaluation of a methadone medical maintenance program

被引:26
作者
Harris, Kenneth A., Jr.
Arnsten, Julia H.
Joseph, Herman
Hecht, Joe
Marion, Ira
Juliana, Patti
Gourevitch, Marc N.
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Van Etten Clin, Dept Psychiat & Behav Sci, Div Substance Abuse, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Div Gen Internal Med, Bronx, NY 10461 USA
[3] Montefiore Med Ctr, Bronx, NY 10461 USA
[4] Rockefeller Univ, New York, NY 10021 USA
[5] Beth Israel Med Ctr, Methodone Maitenance Treatment Program, New York, NY 10003 USA
[6] NYU, Sch Med, Dept Med, Div Gen Internal Med, New York, NY 10003 USA
关键词
methadone; opioid-related disorders; substance abuse; intravenous; substance abuse treatment centers; abstinence;
D O I
10.1016/j.jsat.2006.05.018
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Methadone medical maintenance (MMM) is a model for the treatment of opioid dependence in which a monthly supply of methadone is distributed in an office setting, in contrast to more highly regulated settings where daily observed dosing is the norm. We assessed patient characteristics and treatment outcomes of an MMM program initiated in the Bronx, New York, in 1999 by conducting a retrospective chart review. Participant characteristics were compared with those of patients enrolled in affiliated conventional methadone maintenance treatment programs. Patients had diverse ethnicities, occupations, educational backgrounds, and income levels. Urine toxicology testing detected illicit opiate and cocaine use in 0.8% and 0.4% of aggregate samples, respectively. The retention rate was 98%, which compares favorably with the four other MMM programs that have been reported in the medical literature. This study demonstrates that selected patients from a socioeconomically disadvantaged population remained clinically stable and engaged in treatment in a far less intensive setting than traditional methadone maintenance. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:433 / 438
页数:6
相关论文
共 38 条
[1]  
ANGLIN MD, 1989, ADDICT BEHAV, V14, P307
[2]  
[Anonymous], 2003, COCHRANE DB SYST REV
[3]  
Ball J.C., 1991, EFFECTIVENESS METHAD
[4]  
Barnett PG, 2000, MT SINAI J MED, V67, P365
[5]   A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence [J].
Barnett, PG ;
Rodgers, JH ;
Bloch, DA .
ADDICTION, 2001, 96 (05) :683-690
[6]   Census of patients receiving methadone treatment in a general practice [J].
Byrne, A ;
Wodak, A .
ADDICTION RESEARCH, 1996, 3 (04) :341-349
[7]  
Des Jarlais D C, 1985, NIDA Res Monogr, V58, P101
[8]  
Dole V P, 1978, Ann N Y Acad Sci, V311, P181, DOI 10.1111/j.1749-6632.1978.tb16775.x
[9]   A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION - A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE [J].
DOLE, VP ;
NYSWANDER, M .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1965, 193 (08) :646-+
[10]   Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers [J].
Donny, EC ;
Brasser, SM ;
Bigelow, GE ;
Stitzer, ML ;
Walsh, SL .
ADDICTION, 2005, 100 (10) :1496-1509